author-photo

Kristina Althoff

Boston Children's Hospital

29

Papers

503

Citations

Citation Trend

Filter By

Papers (24) Sort By

Journal Conference Others

Covalent‐Allosteric Inhibitors to Achieve Akt Isoform‐Selectivity

2019 Angewandte Chemie
Show All
- Source
- Cite
- Save
Citations (20)
ALK positively regulates MYCN activity through repression of HBP1 expression

2019
Show All
- Source
- Cite
- Save
Citations (0)
RITA displays anti-tumor activity in medulloblastomas independent of TP53 status

2017 Oncotarget
Show All
- Source
- Cite
- Save
Citations (2)
HBP1 is a negative epigenetic regulator of MYCN-driven neuroblastoma through interaction with the PRC2 complex

2017
Show All
- Source
- Cite
- Save
Citations (0)
Targeting tachykinin receptors in neuroblastoma.

2017 Oncotarget
Show All
- Source
- Cite
- Save
Citations (9)
Pharmaceutically inhibiting polo-like kinase 1 exerts a broad anti-tumour activity in retinoblastoma cell lines

2017 Clinical and Experimental Ophthalmology
Show All
- Source
- Cite
- Save
Citations (6)
The GSK461364 PLK1 inhibitor exhibits strong antitumoral activity in preclinical neuroblastoma models

2017 Oncotarget
Show All
- Source
- Cite
- Save
Citations (22)
The HBP1 tumor suppressor is a negative epigenetic regulator of MYCN driven neuroblastoma through interaction with the PRC2 complex

2017
Show All
- Source
- Cite
- Save
Citations (0)
The HBP1 tumor suppressor is an epigenetic regulator of MYCN-driven neuroblastoma through interaction with the PRC2 complex

2016
Show All
- Source
- Cite
- Save
Citations (0)
Targeting MYCN-Driven Transcription By BET-Bromodomain Inhibition

2016 Clinical Cancer Research
Show All
- Source
- Cite
- Save
Citations (106)